writes about governing the emerging human biotechnologies in Global
Agenda, the official publication of the World Economic Forum.
Annas is chair of the Health Law Department at the Boston University
School of Public Health and co-founder of Global Lawyers & Physicians.
concludes: "We need to exercise our moral imaginations to create
a structure that can act as a virtual global conscience for the
scientific community pursuing species-altering and potentially species-endangering
biotechnologies. An ethical oversight structure must be global and
should include representatives from governments, industry, non-governmental
organizations and the public….That we can imagine the horrors
of an avian flu pandemic or a bioterrorist attack, but cannot imagine
ways to develop and exercise a "species conscience", is
a potentially lethal attribute of today's humans."
Read the full
text of the article: "Governing
The same issue
of Global Agenda includes an article
by Gregory Stock, the UCLA professor and biotech industry executive
who advocates that biomedical researchers apply their techniques
to the genetic modification of future generations to select gender,
personality traits, and other characteristics.
say human enhancement will shape competition of the future,"
Associated Press (January 26).